Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
49 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
Rank Status Study
1 Recruiting Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: hydrocortisone ophthalmic ointment 0.5%;   Drug: placebo
2 Recruiting Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients
Condition: Ligneous Conjunctivitis
Intervention: Biological: Human Plasminogen
3 Unknown  Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
Conditions: Bacterial Conjunctivitis;   Acute
Interventions: Drug: MAXINOM®;   Drug: Maxitrol®
4 Unknown  Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
5 Unknown  Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: Tobracort;   Drug: Tobradex
6 Recruiting Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Auriclosene Ophthalmic Solution;   Drug: Vehicle Ophthalmic Solution
7 Unknown  Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
8 Recruiting Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in Environmental Exposure Chamber
Condition: Allergic Rhino-Conjunctivitis
Intervention: Drug: AllerT
9 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
10 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
11 Recruiting ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
12 Recruiting Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis;   Atopic Dermatitis
Interventions: Biological: XmAb7195;   Biological: Placebo
13 Unknown  A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Condition: Allergic Conjunctivitis
Intervention:
14 Recruiting Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
Condition: Allergic Conjunctivitis
Interventions: Drug: Olopatadine Hydrochloride Ophthalmic Solution 0.2%;   Drug: Olopatadine Hydrochloride Ophthalmic Solution 0.1%;   Drug: Olopatadine 0.2% Vehicle
15 Recruiting A Multi-Center Study Evaluating the Safety of AC-170 0.24%
Condition: Atopc Disease (Including Allergic Conjunctivitis)
Interventions: Drug: Drug: AC-170 0.24%;   Drug: AC-170 0%
16 Recruiting Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
Condition: Viral Conjunctivitis
Interventions: Drug: APD-209 Eye drops;   Drug: APD-209 Placebo Eye drops
17 Recruiting The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
Conditions: Allergic Rhinitis;   Asthma;   Allergic Conjunctivitis
Intervention: Drug: Allergen(Tree, Grass, Weeds)
18 Unknown  The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
Conditions: Allergic Rhinitis;   Asthma;   Allergic Conjunctivitis;   Atopic Dermatitis
Intervention:
19 Unknown  A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
20 Unknown  Ocular Allergy Treatment Practical Impact Trial
Conditions: Allergic Conjunctivitis;   Rhinoconjunctivitis
Intervention: Drug: Alcaftadine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years